Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.41% |
| 5 | Industrials | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Castle Biosciences
CSTL
$933M
| $965K | ﹤0.01% |
+25,600
| New | +$875K |
|
|
ECOM
2127
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $965K | ﹤0.01% |
60,900
+10,000
| +20% | +$116K |
|
|
AGEN
2128
Agenus
AGEN
$315M
| $964K | ﹤0.01% |
12,498
+1,111
| +10% | +$66.5K |
|
2129
Monarch Casino & Resort
MCRI
$2.2B
| $961K | ﹤0.01% |
28,211
+3,700
| +15% | +$123K |
|
2130
First Financial Corp
THFF
$975M
| $959K | ﹤0.01% |
26,026
+5,000
| +24% | +$170K |
|
2131
Liberty Latin America Class A
LILA
$1.67B
| $953K | ﹤0.01% |
153,056
+20,148
| +15% | +$132K |
|
2132
National Presto Industries
NPK
$987M
| $953K | ﹤0.01% |
10,900
+1,400
| +15% | +$119K |
|
|
ATRS
2133
DELISTED
Antares Pharma, Inc.
ATRS
| $952K | ﹤0.01% |
346,100
+45,400
| +15% | +$127K |
|
2134
Chefs' Warehouse
CHEF
$4.57B
| $948K | ﹤0.01% |
69,800
+19,800
| +40% | +$273K |
|
2135
Garrett Motion
GTX
$5.35B
| $946K | ﹤0.01% |
170,800
+25,700
| +18% | +$125K |
|
|
DBD
2136
DELISTED
Diebold Nixdorf Incorporated
DBD
| $944K | ﹤0.01% |
155,759
+14,300
| +10% | +$70.5K |
|
|
KBAL
2137
DELISTED
Kimball International
KBAL
| $944K | ﹤0.01% |
81,700
+10,500
| +15% | +$120K |
|
2138
E.W. Scripps
SSP
$310M
| $943K | ﹤0.01% |
107,816
+14,200
| +15% | +$114K |
|
|
MEET
2139
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $942K | ﹤0.01% |
+151,000
| New | +$930K |
|
2140
Tredegar Corp
TG
$278M
| $938K | ﹤0.01% |
60,900
+9,200
| +18% | +$142K |
|
2141
InMode
INMD
$875M
| $935K | ﹤0.01% |
+66,000
| New | +$883K |
|
|
AD
2142
Array Digital Infrastructure
AD
$3.09B
| $935K | ﹤0.01% |
30,300
+4,600
| +18% | +$142K |
|
2143
Peoples Bancorp
PEBO
$1.49B
| $934K | ﹤0.01% |
43,900
+5,800
| +15% | +$127K |
|
|
EB
2144
DELISTED
Eventbrite
EB
| $933K | ﹤0.01% |
108,900
+14,300
| +15% | +$126K |
|
2145
NexGen Energy
NXE
$6.97B
| $933K | ﹤0.01% |
720,400
+131,800
| +22% | +$168K |
|
|
MSGN
2146
DELISTED
MSG Networks Inc.
MSGN
| $931K | ﹤0.01% |
93,600
+7,900
| +9% | +$90.2K |
|
2147
Hawkins
HWKN
$2.67B
| $928K | ﹤0.01% |
43,588
+6,800
| +18% | +$129K |
|
2148
Amneal Pharmaceuticals
AMRX
$6.02B
| $926K | ﹤0.01% |
194,500
-13,600
| -7% | -$56K |
|
|
HSII
2149
DELISTED
Heidrick & Struggles
HSII
| $925K | ﹤0.01% |
42,800
+5,600
| +15% | +$123K |
|
2150
VirnetX Holding Corp
VHC
$64.8M
| $925K | ﹤0.01% |
+7,115
| New | +$871K |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.